Eli Lilly Abandons Weight Loss Pill Trials!
This episode of On The Pen: The Weekly Dose Podcast breaks down four major stories in obesity medicine: the FDA’s approval of Teva’s so-called “generic” Saxenda at a sky-high price, Wegovy’s accelerated approval in MASH, Novo Nordisk’s headline-grabbing but shaky 57% cardiovascular benefit claim, and Eli Lilly’s decision to scrap its oral GLP-1 naperiglipron. We cut through the spin to ask what these developments really mean for patients fighting for access and better treatment options.
Visit All Our Links
https://linktr.ee/manonthemounjaro
GLP-1 Heart Study
https://onthepen.substack.com/p/new-study-glp-1-drugs-protect-the
As seen on YouTube.
Related in [Weight loss]:
- WEIGHT LOSS JOURNEY: HOW I LOST 30 LBS IN 3 WEEKS STEP-BY-STEP | MOTIVATIONAL PURPOSES
- Weight Loss Surgery In Haryana |Dr Amit Garg|Bariatric And Metabolic Surgeon|Best Bariatric Surgeon
- Janelle Rohner Sold A Weight Loss Course… While Secretly On Ozempic
- Weight Loss Truth: Why Eating MORE Helps You Burn Fat | Micro Habit #12 #WeightLossJourney
- 10 Kgs Belly Fat Weight Loss| AT HOME #transformation #fatloss
Other posts:
- Mufasa VS Blue (The Lion King 2019 & 2024/Jurassic World) Fan Made Death Battle Trailer
- I Tried The 600lbs Life Diet
- #yoga #flow #vinyasa #йога #йогаспб #виньяса #йогафлоу #флоу #core #какосвоить #как #стойканаруках
- THE BEST UPCOMING MOVIES 2022 & 2021 (Trailers)
- The Best Upcoming ACTION Movies 2019 & 2020 (Trailer)
